Clinical Trials
Dartmouth Cancer Center Renews NCI Comprehensive Cancer Center Designation
Dartmouth Cancer Center enters its second half-century of continuous funding by the NCI as a designated Comprehensive Cancer Center.
Copper Trial for Triple-Negative Breast Cancer Officially Opens to Patients
In this Q&A, Linda T. Vahdat, MD, explains how cancer cells are master manipulators in the body and a promising way to stop them that she is studying in a new clinical trial.
Making Sense of Clinical Trials: A Video Q&A with Dr. Linda Vahdat
Breast oncologist and clinical researcher Linda Vahdat, MD, answers common questions about the importance of clinical trials.
A New Trial for “Triple Negative”
A promising multi-site clinical trial that has just opened at lead site Dartmouth Cancer Center looks to bring an innovative treatment strategy to one of the most challenging forms of breast cancer.
Clinical trial trend shows better adherence to breast cancer medication
Data from the first year of a large clinical trial shows fewer side effects and better adherence to breast cancer medication when started before surgery.
FLASH meets Mobetron® in advancing radiation therapy cancer research
Radiation oncology boosts FLASH research studies to the next level.
Clinical trials: How progress in medicine is made
In this video highlight, Konstantin Dragnev, MD, connects with Joanne Conroy, MD, to answer: what are clinical trials?
Video: Clinical trials perspectives
Patients, physicians, and scientists share their thoughts about clinical trials at Dartmouth Cancer Center.
A promising new strategy to treat metastatic breast cancer
Results of a recent clinical trial show that alternating estrogen and anti-estrogen therapies is effective in treating metastatic breast cancer
Patients with multiple breast tumors have safe new options
A new research study shows that breast-conserving surgery is a safe treatment option for some patients with multiple breast lesions.